Abstract:The global prevalence of RNA virus infections has presented significant challenges to public health in recent years, necessitating the expansion of its alternative therapeutic library. Due to its evolutional conservation, RNA-dependent RNA polymerase (RdRp) has emerged as a potential target for broad-spectrum antiviral nucleoside analogues. However, after over half a century of structural modification, exploring unclaimed chemical space using frequently-used structural substitution methods to design new nucleoside analogues is challenging. In this study, we explore the use of the "ring-opening" strategy to design new base mimics, thereby using these base mimics to design new nucleoside analogues with broad-spectrum antiviral activities. A total of 29 compounds were synthesized. Their activity against viral RdRp was initially screened using an influenza A virus RdRp high-throughput screening model. Then, the antiviral activity of 38a was verified against influenza virus strain A/PR/8/34 (H1N1), demonstrating a 50% inhibitory concentration (IC50) value of 9.95 μM, which was superior to that of ribavirin (the positive control, IC50 = 11.43 μM). Moreover, 38a also has inhibitory activity against coronavirus 229E with an IC50 of 30.82 μM. In addition, compounds 42 and 46f exhibit an 82% inhibition rate against vesicular stomatitis virus at a concentration of 20 μM and hardly induce cytotoxicity in host cells. This work demonstrates the feasibility of designing nucleoside analogues with "ring-opening" bases and suggests the "ring-opening" nucleosides may have greater polarity, and designing prodrugs is an important aspect of optimizing their antiviral activity. Future research should focus on enhancing the conformational restriction of open-loop bases to mimic Watson-Crick base pairing better and improve antiviral activity.

Design and Synthesis of Bicyclo[4.3.0]nonene Nucleoside Analogues

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Recent Progress in the Syntheses of Carbocyclic Nucleosides

Design of novel broad-spectrum antiviral nucleoside analogues using natural bases ring-opening strategy

Preparation of Bicyclo[1.1.1]pentane-Derived Nucleoside Analogues

Design and Synthesis of 3′-Deoxy-3′-Fluoro-2′-O,3′-C-Vinylene-Linked BicyclicPurine Nucleoside

Synthesis of Antiviral Acyclic C-nucleosides Incorporating 4-Thiazolinones Structure

Design and Synthesis of 3′-Deoxy-3′-Fluoro-2′-<i>O</i>,3′-<i>C</i>-Vinylene-Linked Bicyclic Purine Nucleoside

The hydrazine moiety in the synthesis of modified nucleosides and nucleotides

A short de novo synthesis of nucleoside analogs

Triazole Nucleoside Derivatives Bearing Aryl Functionalities on the Nucleobases Show Antiviral and Anticancer Activity

Design, Diversity-Oriented Synthesis and Biological Evaluation of Novel Heterocycle Derivatives As Non-Nucleoside HBV Capsid Protein Inhibitors.

Synthesis of 1,2,3- Triazole Nucleoside Analogues

Synthesis and Antiviral Activities of Isonucleosides and Their Monophosphates

Synthesis and Characterization of 3 '-Deoxy-3 '-Fluoro-2 '-O,3 '-C-vinylene Linked Bicyclic Uridine

Rational Design And Synthesis Of 2,2-Bisheterocycle Tandem Derivatives As Non-Nucleoside Hepatitis B Virus Inhibitors

Late-Stage Functionalization of Guanine-Based Nucleosides, Nucleotides, and Oligonucleotide: Synthesis and Derivatization of Tricyclic Nucleoside Analogues

Synthetic Methodologies for<i>C</i>-Nucleosides

Design, Synthesis and Primary Biological Evaluation of the Novel 2-Pyridone Derivatives As Potent Non-Nucleoside HBV Inhibitors.

Advances in biocatalytic and chemoenzymatic synthesis of nucleoside analogues

Highly Enantioselective Synthesis and Potential Biological Activity of Chiral Novel Nucleoside Analogues Containing Adenine and Naturally Phenol Derivatives